|
|
颅底脊索瘤放射治疗
|
Abstract:
颅底脊索瘤为少见肿瘤之一，生长缓慢，但具有高的复发倾向。手术是主要治疗手段，由于局部解剖结构影响，手术受到一定限制。通常采取手术后放疗或根治性放疗。随着放疗技术提高，立体定向放疗、调强治疗、质子治疗和碳离子治疗应用越来越广泛。不同放疗技术对生存影响和不良反应也存在差异。本文对颅底脊索瘤放疗的现状进行了综述。
Chordoma of skull base is one of the rare tumors with slow growth but high recurrence tendency. Surgery is the main method of treatment. Due to the influence of local anatomical structure, surgery is limited, usually taking postoperative radiotherapy or radical radiotherapy. With the improve-ment of radiotherapy technology, stereotactic radiotherapy, intensity modulated therapy, proton therapy and carbon ion radiotherapy are more and more widely used. Different radiotherapy tech-niques also have different effects on survival and adverse reactions. In this paper, the current status of radiotherapy for chordoma of skull base is reviewed.
| [1] | Ulici, V. and Hart, J. (2022) Chordoma. Archives of Pathology & Laboratory Medicine, 146, 386-395.
https://doi.org/10.5858/arpa.2020-0258-RA |
| [2] | Wasserman, J.K., Gravel, D. and Purgina, B. (2018) Chordoma of the Head and Neck: A Review. Head and Neck Pathology, 12, 261-268. https://doi.org/10.1007/s12105-017-0860-8 |
| [3] | Karele, E.N. and Paze, A.N. (2022) Chordoma: To Know Means to Recognize. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1877, Article ID: 188796. https://doi.org/10.1016/j.bbcan.2022.188796 |
| [4] | Kano, H., Niranjan, A. and Lunsford, L.D. (2019) Radiosurgery for Chordoma and Chondrosarcoma. Progress in Neurological Surgery, 34, 207-214. https://doi.org/10.1159/000493066 |
| [5] | Imai, R., Kamada, T., Tsuji, H., Yanagi, T., Baba, M., Miyamoto, T., et al. (2004) Carbon Ion Radiotherapy for Unresectable Sacral Chordomas. Clinical Cancer Research, 10, 5741-5746.
https://doi.org/10.1158/1078-0432.CCR-04-0301 |
| [6] | Kremenevski, N., Schlaffer, S.M., Coras, R., Kinfe, T.M., Graillon, T. and Buchfelder, M. (2020) Skull Base Chordomas and Chondrosarcomas. Neuroendocrinology, 110, 836-847. https://doi.org/10.1159/000509386 |
| [7] | Stacchiotti, S. and Sommer, J. (2015) Building a Global Con-sensus Approach to Chordoma: A Position Paper from Themedical and Patient Community. The Lancet Oncology, 16, e71-e83.
https://doi.org/10.1016/S1470-2045(14)71190-8 |
| [8] | Passer, J.Z., Alvarez-Breckenridge, C., Rhines, L., DeMonte, F., Tatsui, C. and Raza, S.M. (2021) Surgical Management of Skull Base and Spine Chordomas. Current Treatment Op-tions in Oncology, 22, Article No. 40.
https://doi.org/10.1007/s11864-021-00838-z |
| [9] | Choy, W., Terterov, S., Kaprealian, T.B., et al. (2015) Predictors of Recurrence Following Resection of Intracranial Chordomas. Journal of Clinical Neuroscience, 22, 1792-1796. https://doi.org/10.1016/j.jocn.2015.05.024 |
| [10] | Rotondo, R.L., Folkert, W., Liebsch, N.J., et al. (2015) High-Dose Proton-Based Recent Advances in Understanding and Managing Chordomas: An Update Radiation Therapy in the Man-agement of Spine Chordomas: Outcomes and Clinicopathological Prognostic Factors. Journal of Neurosurgery: Spine, 23, 788-797.
https://doi.org/10.3171/2015.3.SPINE14716 |
| [11] | Combs, S.E., Baumert, B.G., Bendszus, M., Bozzao, A., Brada, M., Fariselli, L., Fiorentino, A., Ganswindt, U., Grosu, A.L., Lagerwaard, F.L., Niyazi, M., Nyholm, T., Paddick, I., Weber, D.C., Belka, C. and Minniti, G. (2021) ESTRO ACROP Guideline for Target Volume Delineation of Skull Base Tumors. Radiotherapy and Oncology, 156, 80-94.
https://doi.org/10.1016/j.radonc.2020.11.014 |
| [12] | Mercado, C.E., Holtzman, A.L., Rotondo, R., Rutenberg, M.S. and Mendenhall, W.M. (2019) Proton Therapy for Skull Base Tumors: A Review of Clinical Outcomes for Chordomas and Chondrosarcomas. Head & Neck, 41, 536-541.
https://doi.org/10.1002/hed.25479 |
| [13] | Trifiletti, D.M. and Brown, P.D. (2020) Proton and Carbon Ion Therapy for Skull Base Chordomas. Neuro-Oncology, 22, 1241-1242. https://doi.org/10.1093/neuonc/noaa169 |
| [14] | Takagi, M., Demizu, Y., Nagano, F., Terashima, K., Fujii, O., Jin, D., Mima, M., Niwa, Y., Katsui, K., Suga, M., Yamashita, T., Akagi, T., Sakata, K.I., Fuwa, N. and Okimoto, T. (2018) Treatment Outcomes of Proton or Carbon Ion Therapy for Skull Base Chordoma: A Retrospective Study. Radiation Oncology, 13, Article No. 232.
https://doi.org/10.1186/s13014-018-1173-0 |
| [15] | Yaniv, D., Soudry, E., Strenov, Y., Cohen, M.A. and Mizrachi, A. (2020) Skull Base Chordomas Review of Current Treatment Paradigms. World Journal of Otorhinolaryngology—Head and Neck Surgery, 6, 125-131.
https://doi.org/10.1016/j.wjorl.2020.01.008 |
| [16] | Rich, T.A., Schiller, A., Suit, H.D. and Mankin, H.J. (1985) Clin-ical and Pathologic Review of 48 Cases of Chordoma. Cancer, 56, 182-187. https://doi.org/10.1002/1097-0142(19850701)56:1<182::AID-CNCR2820560131>3.0.CO;2-J |
| [17] | Fossati, P., Vavassori, A., Deantonio, L., Ferrara, E., Krengli, M. and Orecchia, R. (2016) Review of Photon and Proton Radiother-apy for Skull Base Tumours. Reports of Practical Oncology and Radiotherapy, 21, 336-355.
https://doi.org/10.1016/j.rpor.2016.03.007 |
| [18] | Krishnan, S., Foote, R.L., Brown, P.D., Pollock, B.E., Link, M.J. and Garces, Y.I. (2005) Radiosurgery for Cranial Base Chordomas and Chondrosarcomas. Neurosurgery, 56, 777-784.
https://doi.org/10.1227/01.NEU.0000156789.10394.F5 |
| [19] | Debus, J., Schulz-Ertner, D., Schad, L., Essig, M., Rhein, B., Thillmann, C.O. and Wannenmacher, M. (2000) Stereotactic Fractionated Radiotherapy for Chordomas and Chondrosarcomas of the Skull Base. International Journal of Radiation Oncology, Biology, Physics, 47, 591-596. https://doi.org/10.1016/S0360-3016(00)00464-8 |
| [20] | Sahgal, A., Chan, M.W., Atenafu, E.G., Masson-Cote, L., Bahl, G., Yu, E., Millar, B.A., Chung, C., Catton, C., O’Sullivan, B., Irish, J.C., Gilbert, R., Zadeh, G., Cusimano, M., Gentili, F. and Laperriere, N.J. (2015) Image-Guided, Intensity-Modulated Radiation Therapy (IG-IMRT) for Skull Base Chordoma and Chondrosarcoma: Preliminary Outcomes. Neuro-Oncology, 17, 889-894. https://doi.org/10.1093/neuonc/nou347 |
| [21] | Martin, J.J., Niranjan, A., Kondziolka, D., Flickinger, J.C., Lozanne, K.A. and Lunsford, L.D. (2007) Radiosurgery for Chordomas and Chondrosarcomas of the Skull Base. Journal of Neu-rosurgery, 107, 758-764.
https://doi.org/10.3171/JNS-07/10/0758 |
| [22] | Evans, L.T., DeMonte, F., Grosshans, D.R., Ghia, A.J., Habib, A. and Raza, S.M. (2020) Salvage Therapy for Local Progression Following Definitive Therapy for Skull Base Chordomas: Is There a Role of Stereotactic Radiosurgery? Journal of Neurological Surgery Part B: Skull Base, 81, 97-106. https://doi.org/10.1055/s-0039-1679897 |
| [23] | Nakamura, N., Zenda, S., Tahara, M., Okano, S., Hayashi, R., Hojo, H., Hotta, K., Kito, S., Motegi, A., Arahira, S., Tachibana, H. and Akimoto, T. (2017) Proton Beam Therapy for Olfac-tory Neuroblastoma. Radiotherapy and Oncology, 122, 368-372. https://doi.org/10.1016/j.radonc.2016.12.020 |
| [24] | Catton, C., O’Sullivan, B., Bell, R., Laperriere, N., Cummings, B., Fornasier, V. and Wunder, J. (1996) Chordoma: Long-Term Follow-Up after Radical Photon Irradiation. Radiother-apy and Oncology, 41, 67-72.
https://doi.org/10.1016/S0167-8140(96)91805-8 |
| [25] | Hug, E.B. and Slater, J.D. (2000) Proton Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base. Neurosurgery Clinics of North America, 11, 627-638. https://doi.org/10.1016/S1042-3680(18)30088-3 |
| [26] | Hayashi, Y., Mizumoto, M., Akutsu, H., Takano, S., Matsumura, A., Okumura, T., Kawabe, T., Zenkoh, J., Sakurai, H. and Tsuboi, K. (2016) Hyperfractionated High-Dose Proton Beam Radiotherapy for Clival Chordomas after Surgical Removal. The British Journal of Radiology, 89, Article ID: 20151051. https://doi.org/10.1259/bjr.20151051 |
| [27] | Uhl, M., Mattke, M., Welzel, T., Roeder, F., Oelmann, J., Habl, G., Jensen, A., Ellerbrock, M., J？kel, O., Haberer, T., Herfarth, K. and Debus, J. (2014) Highly Effective Treat-ment of Skull Base Chordoma with Carbon Ion Irradiation Using a Raster Scan Technique in 155 Patients: First Long-Term Results. Cancer, 120, 3410-3417.
https://doi.org/10.1002/cncr.28877 |
| [28] | Iannalfi, A., D’Ippolito, E., Riva, G., Molinelli, S., Gandini, S., Viselner, G., Fiore, M.R., Vischioni, B., Vitolo, V., Bonora, M., Ronchi, S., Petrucci, R., Barcellini, A., Mirandola, A., Russo, S., Vai, A., Mastella, E., Magro, G., Maestri, D., Ciocca, M., Preda, L., Valvo, F. and Orecchia, R. (2020) Proton and Car-bon Ion Radiotherapy in Skull Base Chordomas: A Prospective Study Based on a Dual Particle and a Patient-Customized Treatment Strategy. Neuro-Oncology, 22, 1348-1358. https://doi.org/10.1093/neuonc/noaa067 |
| [29] | Zhou, J., Yang, B., Wang, X. and Jing, Z. (2018) Comparison of the Effectiveness of Radiotherapy with Photons and Particles for Chor-doma after Surgery: A Meta-Analysis. World Neurosurgery, 117, 46-53.
https://doi.org/10.1016/j.wneu.2018.05.209 |
| [30] | Connors, S.W., Aoun, S.G., Shi, C., Peinado-Reyes, V., Hall, K. and Bagley, C.A. (2020) Recent Advances in Understanding and Managing Chordomas: An Update. F1000Research, 9, 713.
https://doi.org/10.12688/f1000research.22440.1 |
| [31] | Freeman, J.L., Kaufmann, A.B., Everson, R.G., DeMonte, F. and Raza, S.M. (2019) Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression. Operative Neurosurgery (Hagerstown), 16, 27-36. https://doi.org/10.1093/ons/opy073 |
| [32] | Raza, S.M., Bell, D., Freeman, J.L., Grosshans, D.R., Fuller, G.N. and DeMonte, F. (2018) Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Operative Neurosurgery (Hagerstown), 15, 131-143. https://doi.org/10.1093/ons/opx201 |
| [33] | Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Bau-mann, M., Blay, J.Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, A., Froelich, S., Gardner, PA., Gelderblom, H., Gokaslan, Z.L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, RL., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin, Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O.J., Patel, S., Penel, N., Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K.A., Timmermann, B., Torri, V., Tunn, P.U., Uhl, M., Yamada, Y., Weber, D.C., Vanel, D., Varga, P.P., Vleggeert-Lankamp, C.L.A., Casali, P.G. and Sommer, J. (2017) Best Practices for the Management of Local-Regional Recurrent Chordoma: A Position Paper by the Chordoma Global Consensus Group. Annals of Oncology, 28, 1230-1242.
https://doi.org/10.1093/annonc/mdx054 |
| [34] | Alahmari, M. and Temel, Y. (2019) Skull Base Chordoma Treated with Proton Therapy: A Systematic Review. Surgical Neurology International, 10, Article No. 96. https://doi.org/10.25259/SNI-213-2019 |
| [35] | Morimoto, Y., Tamura, R., Ohara, K., Kosugi, K., Oishi, Y., Kuranari, Y., Yoshida, K. and Toda, M. (2019) Prognostic Significance of VEGF Receptors Expression on the Tumor Cells in Skull Base Chordoma. Journal of Neuro-Oncology, 144, 65-77. https://doi.org/10.1007/s11060-019-03221-z |
| [36] | Guan, X., Gao, J., Hu, J., Hu, W., Yang, J., Qiu, X., Hu, C., Kong, L. and Lu, J.J. (2019) The Preliminary Results of Proton and Carbon Ion Therapy for Chordoma and Chondro-sarcoma of the Skull Base and Cervical Spine. Radiation Oncology, 14, Article No. 206. https://doi.org/10.1186/s13014-019-1407-9 |
| [37] | Gatfield, E.R., Noble, D.J., Barnett, G.C., Early, N.Y., Hoole, A.C.F., Kirkby, N.F., Jefferies, S.J. and Burnet, N.G. (2018) Tumour Volume and Dose Influence Outcome after Sur-gery and High-Dose Photon Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine. Clinical Oncology, 30, 243-253.
https://doi.org/10.1016/j.clon.2018.01.002 |
| [38] | Zhou, J., Jiang, Y., Zhang, H., Chen, L., Luo, P., Li, L., Zhao, J., Lv, F., Zou, D., Zhang, Y. and Jing, Z. (2019) Clinicopathological Implications of TIM3+ Tumor-Infiltrating Lympho-cytes and the MiR-455-5p/Galectin-9 Axis in Skull Base Chordoma Patients. Cancer Immunology, Immunotherapy, 68, 1157-1169.
https://doi.org/10.1007/s00262-019-02349-1 |
